Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Journal of Pharmacology and Toxicology
  Year: 2006 | Volume: 1 | Issue: 2 | Page No.: 115-125
DOI: 10.3923/jpt.2006.115.125
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Interactions of Cyclooxygenase Inhibitors with Reactive Oxygen Species

Sheikh A. Saeed, Muhammad A. Mesaik, J. Quadri, S. Tasneem, A. Motiwala, U. Khalid, Syed U. Ali, Faisal Hussain and Muhammad I. Choudhary

Abstract:
Reactive oxygen species (ROS) are a natural means of defense in the body produced mainly by phagocytic and mast cells. However, their overproduction plays an important role in the pathogenesis of numerous diseases, such as atherosclerosis, cancer, myocardial infarction (MI) and other chronic inflammatory diseases. This review attempts to present our understanding in the interaction of anti-inflammatory drugs with ROS. It has been proposed that in addition to inhibition of prostaglandin synthesis, the anti-inflammatory actions of non-steroidal anti-inflammatory drugs (NSAIDs) may also be due to their free radical scavenging effect. The action of NSAIDs has been demonstrated against an array of ROS, including O-2, OH-, HOCl, as well as various Reactive Nitrogen Species (RNS) such as nitric oxide (NO) and peroxynitrite (ONOO)-. NSAIDs are thought to compete with chloride for the active site of myeloperoxidase (MPO), thereby inhibiting HOCl strong oxidant radical production.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Sheikh A. Saeed, Muhammad A. Mesaik, J. Quadri, S. Tasneem, A. Motiwala, U. Khalid, Syed U. Ali, Faisal Hussain and Muhammad I. Choudhary, 2006. Interactions of Cyclooxygenase Inhibitors with Reactive Oxygen Species. Journal of Pharmacology and Toxicology, 1: 115-125.

DOI: 10.3923/jpt.2006.115.125

URL: https://scialert.net/abstract/?doi=jpt.2006.115.125

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

Curve Bottom